Assetmark Inc. Sells 1,443 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Assetmark Inc. lowered its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 70,802 shares of the biopharmaceutical company’s stock after selling 1,443 shares during the quarter. Assetmark Inc. […]
Assetmark Inc. lowered its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 70,802 shares of the biopharmaceutical company’s stock after selling 1,443 shares during the quarter. Assetmark Inc. […]
